Firzacorvir
| CAS No. | 2243747-96-6 | Cat. No. | BCP49470 |
| Name | Firzacorvir | ||
| Synonyms | ABI-2158;ABI-H2158; | ||
| Formula | C18H18ClFN6O3S2 | M. Wt | 484.95 |
| Description | ABI-H2158 is an HBV core inhibitor that advanced into Phase 2 clinical trials for the treatment of chronic hepatitis B virus infection (cHBV) but was discontinued due to hepatotoxicity. | ||
| Pathways | Microbiology/Virology | ||
| Targets | HBV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.